Sign in

CIK 0001622229

  • Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465308248
Phone
+1 617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,689,493
in 1 filing, $1.7M under 10b5-1 plans

Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Morris Arlene −$1.7M Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2019-06-14 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +7,881 $1.67 $13K 7,881
2019-04-01 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +4,829 $2.72 $13K 4,829
2019-01-02 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +4,860 $2.70 $13K 4,860
2018-10-01 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +2,111 $6.22 $13K 2,111
2018-07-26 Ratcliffe Liam Director Grant or award · Stock Option (Right to Buy) +1,504 $8.72 $13K 1,504
2018-04-03 Ratcliffe Liam Director Conversion +622,772 622,772
2018-04-03 Ratcliffe Liam Director Conversion +622,773 622,773
2018-04-03 Ratcliffe Liam Director Purchase +275,000 $12.00 $3.3M 897,772
2018-04-03 Ratcliffe Liam Director Purchase +275,000 $12.00 $3.3M 897,773
2018-04-03 Ratcliffe Liam Director Conversion · Series B Preferred Stock −977,835 0
2018-04-03 Ratcliffe Liam Director Conversion · Series B Preferred Stock −977,836 0

Page 1 of 1 · 11 trades